By Karolina Tagaris ATHENS (Reuters) – Refugees and migrants in Greece receive little or no medical care for most health problems they face and fewer than half of those pregnant had access to maternal care, aid group Doctors of the World said on Tuesday. About 60,000 migrants and refugees are stranded in Greece, most in […]
Read More
LYON, France (Reuters) – French police searched German drugmaker Merck KGaA’s plant in Lyon on Tuesday as part of an investigation into complaints by patients about changes to its thyroid drug Levothyrox, a company spokeswoman said. A Merck KGaA spokeswoman said the company was “ready to help investigators with their work.” The search was carried […]
Read More
ZURICH (Reuters) – Lonza Group is acquiring a clinical-stage mammalian manufacturing site in the United States from Shire PLC, the Swiss pharmaceutical ingredients group said on Tuesday without giving the purchase price. The site in California has a successful regulatory track record and includes single-use bioreactors and associated downstream capabilities, Lonza said. The site employs […]
Read More
By Toby Sterling and Eric Auchard AMSTERDAM/LONDON (Reuters) – Dutch start-up messaging company MessageBird has landed $60 million in first-round funding, the largest ever early-stage venture capital investment into a European software company. MessageBird helps 15,000 organizations send messages or communicate with customers via chat, voice or video. Clients range from companies such as Uber, […]
Read More
By Environment Correspondent Alister Doyle OSLO (Reuters) – Forty Roman Catholic groups said on Tuesday they were shunning investments in fossil fuels and urged others to follow suit. The coalition was the largest number of Catholic institutions, in countries including Australia, South Africa, Britain and the United States, to team up for a shift to […]
Read More
By Norihiko Shirouzu and Joseph White BEIJING/DETROIT (Reuters) – U.S. automaker Ford Motor Co <F.N> is overhauling its China plans as its global “One Ford” strategy is holding it back in the world’s biggest auto market, two high-ranking company insiders told Reuters. The review of its China operations, part of a broader strategy re-think under […]
Read More
By Salvador Rodriguez SAN FRANCISCO (Reuters) – Slack Technologies Inc has secured a partnership with Oracle Corp <ORCL.N> to integrate the tech giant’s enterprise software products into the popular workplace messaging app, the two companies told Reuters. The partnership is a victory for Slack as the young startup ramps up its efforts to win the […]
Read More
By Conor Humphries DUBLIN (Reuters) – Ireland’s High Court on Tuesday said it would ask the EU’s top court to decide whether to ban the way in which Internet firms such as Facebook <FB.O> transfer users’ data to the United States in a case with major implications for companies. The case is the latest to […]
Read More
By Eric Auchard LONDON (Reuters) – London-based Moo is doubling its sales every three years and proving that there is a place for a premium-priced business card printer in a digital age. On Tuesday, the decade-old member of the city’s Silicon Roundabout tech scene posted 38 percent revenue growth for 2016 and a strengthened executive […]
Read More
PARIS (Reuters) – Amazon <AMZN.O> has approached various French supermarket operators – including Casino <CASP.PA> – about setting up distribution deals or making an acquisition in the country, newspaper Le Monde reported, citing its own sources. Le Monde said Amazon had contacted Casino over Casino’s Monoprix division, but Casino had declined to pursue the matter. […]
Read More
LONDON (Reuters) – British actor Steve Coogan won damages on Tuesday from Mirror Group Newspapers whose reporters illegally listened to his voicemail messages to get scoops, the latest chapter in a long-running saga that has damaged the reputation of the British press. Best known in Britain for his portrayal of fictional radio presenter Alan Partridge, […]
Read More
By Ben Hirschler LONDON (Reuters) – Access to new medicines and safety checks on existing treatments will be jeopardized if politicians pick a new home for Europe’s London-based drugs regulator that is unacceptable to staff, its executive director told Reuters. Cancer drugs and therapies for rare diseases could be particularly affected by an exodus of […]
Read More
